SCHEMBL4011273

SCHEMBL4011273

CCc1nc(-c2ccc(C)cc2)nc(C(C)C)c1OC(=O)OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 4/20 0.38
ADORA1 P30542 1/20 0.38
GCGR P47871 1/20 0.34
DPP4 P27487 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34
MAPT P10636 5/20 0.33
TP53 P04637 2/20 0.33
CNR1 P21554 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DHPS P49366 1/20 0.33
TSHR P16473 1/20 0.33
PRNP P04156 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
LIPE Q05469 1/20 0.33
NPC1 O15118 1/20 0.33
XBP1 P17861 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4007725 0.89 ADORA3 (0.39) ADORA3GCGRMAPTSMN1; SMN2TSHR
SCHEMBL4010060 0.89 DPP4 (0.36) ADORA3ADORA1GCGRDPP4DPP8
SCHEMBL8038540 0.81 GCGR (0.45) ADORA3ADORA1GCGRDPP4DPP8
SCHEMBL4010063 0.79 CNR1 (0.41) ADORA3MAPTCNR1SMN1; SMN2TSHR
SCHEMBL4011472 0.78 MAPT (0.39) ADORA3GCGRMAPTSMN1; SMN2TSHR
SCHEMBL4010057 0.77 DPP4 (0.48) ADORA3ADORA1GCGRDPP4DPP8
SCHEMBL4014162 0.77 TSHR (0.38) ADORA3ADORA1MAPTTP53CNR1
SCHEMBL4011136 0.75 RAB9A (0.38) MAPTTP53TSHRPRNPL3MBTL1
SCHEMBL4007716 0.75 ADORA3 (0.39) ADORA3MAPTTP53SMN1; SMN2TSHR
SCHEMBL4011132 0.74 DHPS (0.41) ADORA3ADORA1MAPTDHPSHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080248-A1 SUBSTITUTED 2-PHENYLPYRIMIDINE-5-CARBOXYLIC ACIDS AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed